Navigation Links
Numira Biosciences Names New Board Member
Date:8/11/2011

SALT LAKE CITY, Aug. 11, 2011 /PRNewswire/ -- Numira Biosciences, a specialty contract research organization and leader in high resolution, 3D imaging services and visualization software for the life science market, today announced that it has appointed William M. Harrison to its Board of Directors.

Mr. Harrison currently serves as the Chief Executive Officer at VIDA Sciences, a CRO consulting firm based in Kalamazoo, Michigan.  Prior to founding VIDA Sciences, Mr. Harrison held a number of senior management positions at MPI Research, a large international CRO based in Mattawan, Michigan.  Most notably, during his last ten years at MPI, he held the position of President and Chief Operating Officer. Additionally, Mr. Harrison is an active member of the Society of Quality Assurance and serves on the Board of Trustees for the Kalamazoo Valley Community College Foundation and the Borgess Medical Center, as well as serving as a board member for the American Life Sciences Innovation Council.

"We are pleased that Bill has joined our board," said Michael Beeuwsaert, President and CEO of Numira. "His 25 years of senior management and regulatory compliance experience in a high-growth, preclinical services environment will be of great value to Numira as we move to the next level as a company."

About Numira Biosciences

Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries.  Through the combination of several novel technologies and capabilities, we provide clients with an unmatched array of pre-clinical services for their research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other areas of disease and/or therapy.  Moreover, we are a recognized leader in high-resolution, quantitative imaging for drug and device development.  Numira, a privately-held company, is venture-backed by vSpring Captital, the Tech Coast Angels, and Crocker Ventures.   For more information on Numira, please visit www.numirabio.com.


'/>"/>
SOURCE Numira Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
2. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
3. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
4. Neurocrine Biosciences Reports Second Quarter 2011 Results
5. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
6. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
7. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
8. Cell Biosciences Changes Name to ProteinSimple
9. Sofie Biosciences is Awarded a DOE Phase I SBIR to Commercialize Microscale Radiochemistry Platform
10. SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
11. Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
Breaking Biology News(10 mins):